Tech Company M&A Transactions
DVS Sciences Acquisition
On 1/29/2014, DVS Sciences was acquired by Fluidigm. Fluidigm said the transaction price was $207.5 million.
Transaction Overview
Company Name
Acquired By
Announced On
1/29/2014
Transaction Type
M&A
Amount
$207,500,000
M&A Terms
The deal will be paid for with all cash.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
639 N. Pastoria Ave.
Sunnyvale, CA 94085
USA
Sunnyvale, CA 94085
USA
Phone
Website
Email Address
Not Recorded
Overview
DVS Sciences Inc. is an analytical equipment and reagents development company that produces and markets the CyTOF, a high throughput mass cytometer for individual cell analysis based on a novel elemental mass-spectrometry detection technology, and the MAXPAR system of reagents related to massively multi-parametric assays.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Victor
Chief Financial Officer
Mark Tenboer
Chief Technical Officer
Scott Tanner
Co-Founder
Dmitry Bandura
Co-Founder
Vladimir Baranov
Co-Founder
Olga Ornatsky
VP - Operations
Pam Delucchi
VP - Sales
Neil Kennedy
Browse more venture capital transactions:
Prev: 1/29/2014: RealtyShares venture capital transaction
Next: 1/29/2014: Shockwave Medical venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs